Bryce Lakely

1.3k total citations
16 papers, 619 citations indexed

About

Bryce Lakely is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Bryce Lakely has authored 16 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Bryce Lakely's work include Prostate Cancer Treatment and Research (12 papers), Cancer Cells and Metastasis (4 papers) and Bone health and treatments (3 papers). Bryce Lakely is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer Cells and Metastasis (4 papers) and Bone health and treatments (3 papers). Bryce Lakely collaborates with scholars based in United States, China and Macao. Bryce Lakely's co-authors include Colm Morrissey, Peter S. Nelson, Ilsa M. Coleman, Robert L. Vessella, Eva Corey, Hung‐Ming Lam, Bruce Montgomery, Paul H. Lange, Lisha G. Brown and Celestia S. Higano and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Bryce Lakely

15 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryce Lakely United States 13 378 295 239 208 68 16 619
Karin Welén Sweden 16 249 0.7× 223 0.8× 177 0.7× 150 0.7× 60 0.9× 20 488
Adam Foye United States 11 461 1.2× 229 0.8× 203 0.8× 324 1.6× 82 1.2× 30 638
Tatsuya Shimomura Japan 9 265 0.7× 203 0.7× 173 0.7× 87 0.4× 69 1.0× 37 469
Antje Krohn Germany 11 437 1.2× 371 1.3× 129 0.5× 213 1.0× 32 0.5× 17 643
Raquel Esgueva United States 8 616 1.6× 454 1.5× 119 0.5× 356 1.7× 40 0.6× 9 867
Μαρία Κάρλου Greece 13 477 1.3× 282 1.0× 177 0.7× 211 1.0× 95 1.4× 19 739
Anette Hauge Norway 13 177 0.5× 151 0.5× 153 0.6× 117 0.6× 119 1.8× 21 471
Jens Enoksson Sweden 6 246 0.7× 532 1.8× 353 1.5× 176 0.8× 59 0.9× 8 763
Catherine J. Kennedy Australia 13 176 0.5× 234 0.8× 194 0.8× 119 0.6× 44 0.6× 25 560
Tanaz Sharifnia United States 8 301 0.8× 496 1.7× 223 0.9× 181 0.9× 15 0.2× 8 715

Countries citing papers authored by Bryce Lakely

Since Specialization
Citations

This map shows the geographic impact of Bryce Lakely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryce Lakely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryce Lakely more than expected).

Fields of papers citing papers by Bryce Lakely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryce Lakely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryce Lakely. The network helps show where Bryce Lakely may publish in the future.

Co-authorship network of co-authors of Bryce Lakely

This figure shows the co-authorship network connecting the top 25 collaborators of Bryce Lakely. A scholar is included among the top collaborators of Bryce Lakely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryce Lakely. Bryce Lakely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Labrecque, Mark P., Lisha G. Brown, Ilsa M. Coleman, et al.. (2023). Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer. The Prostate. 84(1). 100–110. 4 indexed citations
2.
Labrecque, Mark P., Lisha G. Brown, Ilsa M. Coleman, et al.. (2021). RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer. Cancer Research. 81(18). 4736–4750. 23 indexed citations
3.
Garcia, José M., Funda Vakar‐Lopez, Sonali Arora, et al.. (2021). A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture. Scientific Reports. 11(1). 4609–4609. 17 indexed citations
5.
Labrecque, Mark P., Lisha G. Brown, Ilsa M. Coleman, et al.. (2018). Abstract 1092: Defining the molecular phenotypes of metastatic castration-resistant prostate cancer sensitive to FGF pathway inhibition. Cancer Research. 78(13_Supplement). 1092–1092. 1 indexed citations
6.
Henzler, Christine, Yingming Li, Rendong Yang, et al.. (2016). Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer. Nature Communications. 7(1). 13668–13668. 118 indexed citations
7.
Zhang, Xiaotun, Ilsa M. Coleman, Lisha G. Brown, et al.. (2015). SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 21(20). 4698–4708. 129 indexed citations
8.
Zhang, Xiaotun, Ilsa M. Coleman, Nolan G. Ericson, et al.. (2015). Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases. Clinical & Experimental Metastasis. 33(3). 239–248. 27 indexed citations
9.
Ruppender, Nazanin S., Sandy Larson, Bryce Lakely, et al.. (2015). Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy. PLoS ONE. 10(6). e0130565–e0130565. 47 indexed citations
10.
Chéry, Lisly, Hung‐Ming Lam, Ilsa M. Coleman, et al.. (2014). Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways. Oncotarget. 5(20). 9939–9951. 79 indexed citations
11.
Welty, Christopher J., Ilsa M. Coleman, Roger Coleman, et al.. (2013). Single cell transcriptomic analysis of prostate cancer cells. BMC Molecular Biology. 14(1). 6–6. 29 indexed citations
12.
Larson, Sandy, Xiaotun Zhang, Lisha G. Brown, et al.. (2013). Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment. Clinical & Experimental Metastasis. 31(2). 247–256. 18 indexed citations
13.
Larson, Sandy, Xiaotun Zhang, Ruth F. Dumpit, et al.. (2013). Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. The Prostate. 73(9). 932–940. 50 indexed citations
14.
Sun, Jianxun, Orapin V. Horst, Roger E. Bumgarner, et al.. (2012). Laser capture microdissection enables cellular and molecular studies of tooth root development. International Journal of Oral Science. 4(1). 7–13. 16 indexed citations
15.
Morrissey, Colm, Theodore D. Koreckij, Holly M. Nguyen, et al.. (2010). Inhibition of angiopoietin‐2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability. The Prostate. 70(16). 1799–1808. 27 indexed citations
16.
Morgan, Todd M., et al.. (2007). 657: Disseminated Tumor Cells in Prostate Cancer: Implications for Systemic Progression and Tumor Dormancy. The Journal of Urology. 177(4S). 220–221.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026